Neutrophil Elastase Activity Imaging: Recent Approaches in the Design and Applications of Activity-Based Probes and Substrate-Based Probes.
Animals
Asymptomatic Diseases
Biomarkers
Biopolymers
Catalytic Domain
Chromogenic Compounds
Cytoplasmic Granules
/ enzymology
Early Diagnosis
Enzyme-Linked Immunosorbent Assay
/ methods
Fluorescence Resonance Energy Transfer
Fluorescent Dyes
Humans
Imaging, Three-Dimensional
/ methods
Leukocyte Elastase
/ analysis
Magnetic Resonance Imaging
/ methods
Molecular Imaging
/ instrumentation
Neutrophils
/ enzymology
Oligopeptides
Optical Imaging
/ methods
Pneumonia
/ diagnostic imaging
Positron-Emission Tomography
/ methods
Proteolysis
Substrate Specificity
Journal
Contrast media & molecular imaging
ISSN: 1555-4317
Titre abrégé: Contrast Media Mol Imaging
Pays: England
ID NLM: 101286760
Informations de publication
Date de publication:
2019
2019
Historique:
received:
28
03
2019
accepted:
19
05
2019
entrez:
9
7
2019
pubmed:
10
7
2019
medline:
22
7
2020
Statut:
epublish
Résumé
The last few decades of protease research has confirmed that a number of important biological processes are strictly dependent on proteolysis. Neutrophil elastase (NE) is a critical protease in immune response and host defense mechanisms in both physiological and disease-associated conditions. Particularly, NE has been identified as a promising biomarker for early diagnosis of lung inflammation. Recent studies have shown an increasing interest in developing methods for NE activity imaging both in vitro and in vivo. Unlike anatomical imaging modalities, functional molecular imaging, including enzymatic activities, enables disease detection at a very early stage and thus constitutes a much more accurate approach. When combined with advanced imaging technologies, opportunities arise for measuring imbalanced proteolytic activities with unprecedented details. Such technologies consist in building the highest resolved and sensitive instruments as well as the most specific probes based either on peptide substrates or on covalent inhibitors. This review outlines strengths and weaknesses of these technologies and discuss their applications to investigate NE activity as biomarker of pulmonary inflammatory diseases by imaging.
Identifiants
pubmed: 31281234
doi: 10.1155/2019/7417192
pmc: PMC6594253
doi:
Substances chimiques
Biomarkers
0
Biopolymers
0
Chromogenic Compounds
0
Fluorescent Dyes
0
Oligopeptides
0
ELANE protein, human
EC 3.4.21.37
Leukocyte Elastase
EC 3.4.21.37
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
7417192Références
Oncotarget. 2014 Jan 30;5(2):473-80
pubmed: 24457622
Expert Opin Ther Targets. 2008 Feb;12(2):145-57
pubmed: 18208364
Am Rev Respir Dis. 1981 Nov;124(5):613-8
pubmed: 6914147
Nat Biotechnol. 1999 Apr;17(4):375-8
pubmed: 10207887
FEBS Lett. 1975 Feb 15;50(3):359-61
pubmed: 1116607
Am J Respir Crit Care Med. 1994 Aug;150(2):448-54
pubmed: 8049828
Pediatr Pulmonol. 2005 Dec;40(6):500-10
pubmed: 16208679
Contrast Media Mol Imaging. 2014 Sep-Oct;9(5):363-71
pubmed: 24729587
J Nucl Med. 2000 Feb;41(2):363-74
pubmed: 10688123
PLoS One. 2009;4(4):e5244
pubmed: 19396361
Nat Commun. 2015 Oct 01;6:8448
pubmed: 26423607
Chimia (Aarau). 2016 Nov 30;70(11):787-795
pubmed: 28661339
Analyst. 2016 Mar 7;141(5):1645-8
pubmed: 26858995
Magn Reson Med. 2014 Mar;71(3):1221-30
pubmed: 23640714
Biol Chem. 2008 Jun;389(6):747-56
pubmed: 18627291
Science. 1989 Aug 11;245(4918):616-21
pubmed: 2548279
PLoS One. 2013 Sep 20;8(9):e75141
pubmed: 24073241
Chem Rev. 2002 Dec;102(12):4501-24
pubmed: 12475199
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):525-533
pubmed: 28062502
J Histochem Cytochem. 2003 Jun;51(6):821-9
pubmed: 12754293
Anal Biochem. 2012 Feb 15;421(2):667-72
pubmed: 22178917
PLoS One. 2016 Aug 17;11(8):e0160522
pubmed: 27532109
Chem Biol. 1997 Nov;4(11):809-16
pubmed: 9384527
Nat Protoc. 2008;3(6):991-1000
pubmed: 18536646
Biochim Biophys Acta. 1977 Nov 23;485(1):156-66
pubmed: 562189
Am J Respir Crit Care Med. 2017 May 15;195(10):1384-1393
pubmed: 27911604
Contrast Media Mol Imaging. 2012 Jan-Feb;7(1):45-50
pubmed: 22344879
Biochem Soc Trans. 2005 Apr;33(Pt 2):331-4
pubmed: 15787599
Carbohydr Polym. 2015 Feb 13;116:278-85
pubmed: 25458301
Nat Rev Immunol. 2006 Jul;6(7):541-50
pubmed: 16799473
Chem Sci. 2018 Jan 16;9(8):2113-2129
pubmed: 29719685
Nat Rev Drug Discov. 2006 Sep;5(9):785-99
pubmed: 16955069
Mol Cancer Res. 2017 Sep;15(9):1138-1152
pubmed: 28512253
Rheumatology (Oxford). 2016 Mar;55(3):564-72
pubmed: 26475798
J Biol Chem. 1979 May 25;254(10):4027-32
pubmed: 312290
Am J Respir Crit Care Med. 2009 Jul 15;180(2):146-52
pubmed: 19372250
Neoplasia. 2004 Mar-Apr;6(2):95-105
pubmed: 15140398
Science. 2000 Aug 18;289(5482):1185-8
pubmed: 10947984
J Med Chem. 2018 Jun 28;61(12):5222-5234
pubmed: 29806773
Biochem Med. 1974 Dec;11(4):350-7
pubmed: 4429553
Chem Commun (Camb). 2018 Oct 16;54(83):11785-11788
pubmed: 30277484
Angew Chem Int Ed Engl. 2012 Jun 18;51(25):6258-61
pubmed: 22555935
Int J Mol Imaging. 2011;2011:581406
pubmed: 21941648
J Cyst Fibros. 2002 Dec;1(4):269-75
pubmed: 15463826
Physiol Rev. 2012 Apr;92(2):897-965
pubmed: 22535898
Blood. 1990 Aug 15;76(4):755-66
pubmed: 2116928
Biotechniques. 2004 May;36(5):878-85
pubmed: 15152609
FEBS Lett. 1999 Jun 25;453(3):356-60
pubmed: 10405175
Proc Natl Acad Sci U S A. 1976 Nov;73(11):3825-32
pubmed: 1069267
Curr Opin Chem Biol. 2011 Dec;15(6):798-805
pubmed: 22098719
Respir Med. 2013 Apr;107(4):524-33
pubmed: 23433769
Nat Med. 2001 Jun;7(6):743-8
pubmed: 11385514
J Biol Chem. 2007 May 11;282(19):14645-54
pubmed: 17384412
Br J Pharmacol. 2016 Feb;173(4):766-77
pubmed: 26140667
Eur J Pharmacol. 2002 Sep 6;451(1):1-10
pubmed: 12223222
Nat Med. 1998 May;4(5):615-8
pubmed: 9585238
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2518-23
pubmed: 24550277
Annu Rev Immunol. 2005;23:197-223
pubmed: 15771570
J Appl Physiol (1985). 1986 Feb;60(2):532-8
pubmed: 3512509
N Engl J Med. 2013 May 23;368(21):1963-70
pubmed: 23692169
Chem Biol. 2004 Jan;11(1):99-106
pubmed: 15112999
J Immunol. 2004 Jan 1;172(1):509-15
pubmed: 14688361
Circulation. 2007 May 1;115(17):2292-8
pubmed: 17420353
Anticancer Agents Med Chem. 2012 Jul;12(6):565-79
pubmed: 22263788
Chem Sci. 2016 Feb 1;7(2):1322-1337
pubmed: 29910890
Stem Cells. 2008 Nov;26(11):2981-90
pubmed: 18757301
Contrast Media Mol Imaging. 2016 Mar-Apr;11(2):130-8
pubmed: 26633584
Lancet Respir Med. 2017 Sep;5(9):691-706
pubmed: 28822787
Biochem Biophys Res Commun. 1973 Jul 17;53(2):383-90
pubmed: 4736813
Free Radic Biol Med. 2018 Oct;126:101-112
pubmed: 30092349
J Biol Chem. 2009 Dec 4;284(49):34084-91
pubmed: 19833730
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1929-35
pubmed: 12426227
Respir Res. 2018 Sep 20;19(1):180
pubmed: 30236095
Biochemistry. 2018 Feb 6;57(5):742-752
pubmed: 29286643
Mol Pharm. 2014 Jul 7;11(7):2412-9
pubmed: 24936972
Eur Respir J. 2018 Mar 29;51(3):
pubmed: 29545279
Mol Pharm. 2014 Nov 3;11(11):4208-17
pubmed: 25271556
Biochimie. 2008 Feb;90(2):227-42
pubmed: 18021746
J Thorac Dis. 2010 Dec;2(4):245-52
pubmed: 22263053
ChemMedChem. 2016 Sep 20;11(18):2037-42
pubmed: 27465595
Biol Chem. 2001 May;382(5):785-8
pubmed: 11517931
ACS Chem Biol. 2015 Apr 17;10(4):945-51
pubmed: 25581168
Pulm Pharmacol Ther. 2019 Jun;56:86-93
pubmed: 30917927
J Cell Biol. 1995 Nov;131(3):775-89
pubmed: 7593196
Pharmacol Rev. 2010 Dec;62(4):726-59
pubmed: 21079042
Mol Imaging. 2012 Sep-Oct;11(5):417-25
pubmed: 22954186
Microbes Infect. 2003 Nov;5(14):1317-27
pubmed: 14613775
Org Biomol Chem. 2010 Jun 7;8(11):2560-6
pubmed: 20485791
Am J Pathol. 2014 Aug;184(8):2197-210
pubmed: 24929239
Anal Biochem. 1979 Oct 15;99(1):53-64
pubmed: 394626
J Med Chem. 1996 Mar 1;39(5):1112-24
pubmed: 8676347
Chembiochem. 2014 Nov 24;15(17):2605-12
pubmed: 25236966
Bioconjug Chem. 2009 Nov;20(11):2098-105
pubmed: 19810697
Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62
pubmed: 6035483